Oxycodone is a widely prescribed but highly misused opioid painkiller. As opioid-related harm continues to impact workplaces and healthcare settings, it’s crucial for employers, occupational health teams, and clinicians to understand how oxycodone is detected, what it shows up as, and how to manage testing outcomes.
In this article, we explore how oxycodone appears on drug tests, how long it stays in the system, and what employers and healthcare providers need to know when interpreting test results.
Oxycodone is a semi-synthetic opioid used to treat moderate to severe pain. It is typically prescribed under brand names like OxyContin, Percocet (when combined with paracetamol), and Endocet. While effective when used as directed, oxycodone is also frequently misused for its euphoric effects, making it a major concern in both clinical and workplace environments.
In the United States, oxycodone has played a central role in the opioid epidemic, with widespread overprescription contributing to significant rates of dependency, overdose, and death. While the UK has not seen the same scale of crisis, concerns are rising. Recent trends indicate increasing misuse of prescription opioids across Europe, including the UK, with the European Drug Report 2025 highlighting a rise in opioid-related harms and treatment demand. UK clinicians and employers are being urged to take proactive steps to monitor and manage opioid use more closely to prevent a similar crisis from unfolding.
Yes. Oxycodone will show up on a drug test. However, not all standard drug panels detect it unless specifically included. This is because oxycodone is structurally different from other opiates like morphine or codeine, meaning some basic opiate panels may miss it.
Oxycodone is typically detected as OXY on drug testing strips. Some advanced multi-panel tests, such as 10-, 12-, 14-, and 16-panel drug tests, will include a specific panel for oxycodone to ensure it’s not confused with other opiates.
Both test types can differentiate oxycodone from other opioids and are used in occupational, legal, and clinical settings.
Test Type |
Detection Window |
Urine | 1-4 Days |
Saliva | 1-2 Days |
False positives for oxycodone are uncommon, but can occur with:
If a point-of-care test indicates a non-negative, confirmatory testing using GC-MS or LC-MS is recommended. These lab-based methods eliminate ambiguity and offer accurate identification.
At AttoSure, we use drug test kits with clearly marked strips for oxycodone, typically labeled OXY. This panel specifically detects oxycodone and its major metabolite, oxymorphone.
If the OXY panel shows a positive result, it is marked as a non-negative. This does not necessarily mean the person is impaired at the time of the test—but it does indicate the presence of the substance in their system.
In workplace scenarios, a non-negative test often leads to:
Oxycodone can cause sedation, slowed reaction time, and impaired motor function—posing significant risks in safety-critical roles. That’s why many employers include it in:
Industries where oxycodone testing is especially important include:
Oxycodone is a potent and potentially dangerous prescription opioid. As misuse continues to rise, it’s essential for employers and healthcare professionals to implement reliable testing protocols.
At AttoSure, we provide oxycodone testing solutions through urine and saliva drug test kits, supported by laboratory confirmation and expert consultation.
Contact us today to learn more about workplace and clinical oxycodone testing solutions.
Contact Us